the aid library

LIST OPTIONS

Filter

21725

Catastrophic health expenditure during the COVID-19 pandemic in five countries: a time-series analysis

Haakenstad A., Bintz C., Knight M., et al. Lancet Global Health (2023) CC

The COVID-19 pandemic disrupted health systems in 2020, but it is unclear how financial hardship due to out-of-pocket (OOP) health-care costs was affected. We analysed catastrophic health expenditure (CHE) in 2020 in five countries with available household expenditure data: Belarus, Mexico, Peru, R... more

External Link

External Link (113)

Financing of international collective action for epidemic and pandemic preparedness

Yameya G., Schäferhoff M., Aars O.K., et al. Lancet Global Health (2017) CC

The global pandemic response has typically followed cycles of panic followed by neglect. We are now, once again, in a phase of neglect, leaving the world highly vulnerable to massive loss of life and economic shocks from natural or human-made epidemics and pandemics. Quantifying the size of the... more

External Link

External Link (88)

Redefining Debt‑to‑Health, a triple‑win health financing instrument in global health

Hu Y., Wang Z., Zhou S., et al. Globalization and Health (2024) CC

As a recognized win–win-win approach to international debt relief, Debt-to-Health(D2H)has successfully translated debt repayments into investments in health-related projects. Although D2H has experienced modifications and periodic suspension, it has been playing an increasingly important role in r... more

External Link

External Link (73)

From lemming to leader: Moving beyond Gross Domestic Product (GDP) to bring health financing assistance into the 21st century

Nassiri-Ansari's T., Schwalbe N., Lehtimaki S. PLOS Global Public Health (2024) CC

Nearly 90 years after Simon Kuznets first introduced Gross Domestic Product (GDP) for the limited purpose of measuring economic growth (by measuring the monetary value of all local goods and services within a given period of time), calls continue to mount for decision-makers to stop using GDP and it... more

External Link

External Link (152)

Public Financial Management: A Pathway to Universal Health Coverage in Low-and-Middle Income Countries

Barroy H., Yameogob P., Blecher M., et al. Health Systems & Reform (2024) CC

Achieving universal health coverage (UHC) is a politicalambition in many low- and middle-income countries(LMICs). Public funding has been recognized as funda-mental to the two dimensions of UHC: expanding healthservice coverage and increasing protection against health-related financial hardship. Rel... more

Download (37)

View PDF (33)

Financing Global Health 2023: The Future of Health Financing in the Post-Pandemic Era - Malaria report

Institute for Health Metrics and Evaluation (IHME) - University of Washington (2024) C2

The document is part of the Financing Global Health 2023 series by the Institute for Health Metrics and Evaluation (IHME) and focuses specifically on malaria. It provides a concise overview of global and regional trends in malaria-related health spending, including development assistance, government... more

External Link

External Link (57)

How feasible is it to mobilize $31 billion a year for pandemic preparedness and response? An economic growth modelling analysis

Shahid M., Schäferhoff M., Brown G., et al. Globalization and Health (2024) CC

Covid-19 has reinforced health and economic cases for investing in pandemic preparedness and response (PPR). The World Bank and World Health Organization (WHO) propose that low- and middle-income governments and donor countries should invest $31.1 billion each year for PPR. We analyse, based on the... more

External Link

External Link (63)

Financing for equity for women’s, children’s and adolescents’ health in low- and middleincome countries: A scoping review

Bou-Karroum L., Iaia D.G. , El-Jardali F., et al. PLOS Global Public Health (2024) CC

Over the past few decades, the world has witnessed considerable progress in women’s, children’s and adolescents’ health (WCAH) and the Sustainable Development Goals (SDGs). Yet deep inequities remain between and within countries. This scoping review aims to map financing interventions and meas... more

External Link

External Link (116)

Financialisation: a 21st century commercial determinant of health equity

Friel S., Schram A., Frank N., et al. Lancet Public Health (2024) CC

In 21st century capitalism, financial markets reign supreme. The elevation of investing, trading, and speculating as a way of making profit has shifted economic power towards institutional investors and enhanced the power of financial capital. Financialisation has introduced uncertainty in the commi... more

External Link

External Link (78)

Financing pandemic prevention, preparedness and response: lessons learned and perspectives for future

Ndembi N., Dereje N., Nonvignon J., et al. Globalization and Health (2024) CC

The attainment of global health security goals and universal health coverage will remain a mirage unless African health systems are adequately funded to improve resilience to public health emergencies. The COVID-19 pandemic exposed the global inequity in accessing medical countermeasures, leaving Af... more

External Link (174)

Témoignages de mères face au choléra

ReliefWeb (2025) C2

L'article "Témoignages de mères face au choléra" sur ReliefWeb présente les récits de mères haïtiennes dont les enfants ont été touchés par le choléra. Il met en lumière les défis auxquels ces familles sont confrontées, en particulier dans les régions où l'accès aux soins de santé ... more

External Link (138)

Urgence de santé publique de portée internationale liée à la recrudescence de la mpox (variole simienne) en 2024

World Health Organization WHO (2025) C_WHO

Ces recommandations temporaires sont émises à l’intention des États Parties qui font face à une transmission du virus de la mpox (MPXV), y compris, sans que cette liste soit exhaustive, ceux touchés par une transmission communautaire persistante et ceux où l’on observe des groupes de cas o... more

External Link (661)

European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5–16 years

Gaillard, E.A.; Kuehni, C.E.; Turner, S.; et al. European Respiratory Journal (2021) CC

Diagnosing asthma in children represents an important clinical challenge. There is no single gold-standard test to confirm the diagnosis. Consequently, over- and under-diagnosis of asthma is frequent in children. A task force supported by the European Respiratory Society has developed these evidence... more

External Link (554)

Asthma traeatment in children: A pragmatic approach

Masekela, R.; Jeevanathrum, A.; Kling, S.; et al. South African Medical Journal (2018) CC

Asthma is a heterogeneous condition characterised by chronic inflammation and variable expiratory airflow limitation, with airway reversibility. Management of chronic inflammation with anti-asthma medication improves asthma control and quality of life. The aim of this journal is to provide an eviden... more

External Link

Pollution and the Heart

Rajagopalan, S.; Landrigan, P.J. The New England Journal of Medicine (2021) CC

Cardiovascular diseases are the world’s leading cause of disability and death. Such diseases were responsible in 2019 for an estimated 18.6 million deaths globally and 957,000 deaths in the United States.

Download (106)

View PDF (82)

Country cooperation strategy 2023-2027: Eritrea

World Health Organisation (WHO) (2023) C_WHO

The Country Cooperation Strategy (CCS) is a medium-term strategic framework for cooperation between WHO and countries and outlines a shared agenda with priority areas of work for five years. The aim of this CSS is to define medium term vision for WHO technical cooperation with the State of Eritrea ... more

Download (158)

View PDF (145)

WHO guideline on preventive chemotherapy for public health control of strongyloidiasis
recommended

World Health Organization WHO (2024) C_WHO

Human strongyloidiasis is a chronic parasitic disease caused by infection with Strongyloides stercoralis, a soil-transmitted helminth that is estimated to infect 300–600 million people worldwide. This neglected tropical disease (NTD) is endemic globally, predominately in the South-East Asia, Afric... more

Download (66)

View PDF (70)

Deset koraka do psihičkog zdravlja

Santé Prison Suisse Swiss Centre of Expertise in Prison and Probation SCEPP (2020) CC

Flyer 10 Steps to Mental Health

Download (244)

View PDF (233)

Guidance on Selection and Use of One Health Operational Tools

Food and Agriculture Organization of the United Nations FAO; UN Environment Programme UNEP; World Health Organization WHO; World Organisation for Animal Health WOAH (2024) C_WHO

The One Health (OH) High-Level Expert Panel (OHHLEP) of the Quadripartite Organizations defined OH as an integrated, unifying approach that aims to sustainably balance and optimize the health of people, animals and ecosystems.” It recognizes the health of humans, domestic and wild animals, plan... more

External Link

South African cardiovascular risk stratification guideline for non-cardiac surgery

Alphonsus, C.; Naidoo, N.; Motshabi, P. et al. South African Medical Journal (2021) CC

The South African (SA) guidelines for cardiac patients for non-cardiac surgery were developed to address the need for cardiac risk assessment and risk stratification for elective non-cardiac surgical patients in SA, and more broadly in Africa. The guidelines were developed by updating the Canadian ...Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Non-cardiac Surgery, with a search of literature from African countries and recent publications. The updated proposed guidelines were then evaluated in a Delphi consensus process by SA anaesthesia and vascular surgical experts. The recommendations in these guidelines are: 1. We suggest that elective non-cardiac surgical patients who are 45 years and older with either a history of coronary artery disease, congestive cardiac failure, stroke or transient ischaemic attack, or vascular surgical patients 18 years or older with peripheral vascular disease require further preoperative risk stratification as their predicted 30-day major adverse cardiac event (MACE) risk exceeds 5% (conditional recommendation: moderate-quality evidence). 2. We do not recommend routine non-invasive testing for cardiovascular risk stratification prior to elective non-cardiac surgery in adults (strong recommendation: low-to-moderate-quality evidence). 3. We recommend that elective non-cardiac surgical patients who are 45 years and older with a history of coronary artery disease, or stroke or transient ischaemic attack, or congestive cardiac failure or vascular surgical patients 18 years or older with peripheral vascular disease should have preoperative natriuretic peptide (NP) screening (strong recommendation: high-quality evidence). 4. We recommend daily postoperative troponin measurements for 48 - 72 hours for non-cardiac surgical patients who are 45 years and older with a history of coronary artery disease, or stroke or transient ischaemic attack, or congestive cardiac failure or vascular surgical patients 18 years or older with peripheral vascular disease, i.e. (i) a baseline risk >5% for MACE 30 days after elective surgery (if no preoperative NP screening), or (ii) an elevated B-type natriuretic peptide (BNP)/N-terminal-prohormone B-type natriuretic peptide (NT-proBNP) measurement before elective surgery (defined as BNP >99 pg/mL or a NT-proBNP >300 pg/mL) (conditional recommendation: moderate-quality evidence). Additional recommendations are given for the management of myocardial injury after non-cardiac surgery (MINS) and medications for comorbidities. more

WHO guideline on preventive chemotherapy for public health control of strongyloidiasis ﻿ recommended

WHO guideline on preventive chemotherapy for public health control of strongyloidiasis
recommended